Monir Abousiam
Head & Neck and reconstructive surgeron in the regional hospital of Bolzano, Italy
previous ENT resident in University of Padua
GOLF fellowship graduate in H&N oncology of the IFHNOS
active AIOCC member
main focus in work and research is oral cavity tumors from ablative to reconstructive surgery.
Sessions
clinical and radiological evaluation are fundamental in the decision-making process in tongue cancer.
Pathological aspects of tumor pathways of progression and different structures of the oral cavity involved are in some cases can be trickier to assess.
Radiological workup is made mainly with MRI in order to have a clear vision of all the muscolar e soft tissue components of the oral cavity.
Only after a strict evaluation of these aspects radical excision of the tumor can be programmed.
Recent classification of glossectomies gave a better understanding of how different cases can be correctly handled surgically.
In oral cavity cancer more than in other head and neck districts it is very important to obtain radicality by clear margins in order to obtain the best oncological results. Nevertheless, residual functions like swallowing and speech need to be also considered.
Description: This session will explore recent advancements in oral cavity surgery that balance oncologic control with preservation of function and quality of life. It will highlight innovative surgical approaches, including microvascular free flap reconstruction, and nerve-preserving techniques that minimize morbidity. Emerging trends such as the use of intraoperative imaging, navigation systems, and fluorescence-guided surgery for margin assessment will be discussed. Additionally, the session will examine the role of precision diagnostics and molecular profiling in surgical planning, along with multidisciplinary strategies to enhance functional outcomes in speech, swallowing, and aesthetics following resection.
Outcome Objectives:
Describe current surgical innovations in the treatment of oral cavity cancers, including TORS and advanced reconstructive techniques.
Evaluate the role of image-guided and fluorescence-assisted surgery in achieving clear margins.
Understand the impact of nerve preservation and reconstructive strategies on postoperative function and quality of life.
Integrate molecular and genomic data into surgical planning and risk stratification.
Apply multidisciplinary strategies to optimize oncologic and functional outcomes in oral cavity cancer care.
Background: Oral cavity cancers present a unique clinical challenge, where surgical treatment must achieve clear oncologic margins while preserving critical functions such as speech, swallowing, and appearance. Historically, extensive resections often led to significant morbidity. However, advances in surgical techniques, reconstruction, and perioperative care have markedly improved both survival and quality of life.
Technologies like transoral robotic surgery have enabled more precise resections in anatomically challenging regions, while microvascular free flaps and 3D planning have enhanced reconstructive outcomes. Intraoperative tools such as fluorescence-guided surgery and augmented imaging systems offer real-time assistance in assessing margins, reducing the risk of local recurrence. Moreover, molecular profiling is increasingly used to guide treatment selection and tailor follow-up.
This session is designed for head and neck surgeons, oncologists, and allied specialists committed to delivering high-quality, personalized care in oral cavity surgery. Through expert-led presentations and case-based discussions, attendees will gain practical knowledge to adopt these advances in their clinical practice.